| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10514549 | Journal of Clinical Epidemiology | 2005 | 9 Pages |
Abstract
Crude results of Reflotron-measured cTC have poor sensitivity. Instead, 95% UPL can be used for monitoring and screening. Simply adding 0.8 mmol/L to a patient's observed Reflotron cTC value provides a very good approximation to the 95% UPL.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Michael C. Costanza, Hans Wolff, Richard W. James, Alfredo Morabia,